- Home
- TFPM vs BHC Comparison
TFPM vs BHC Comparison
Compare TFPM & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFPM
- BHC
- Stock Information
- Founded
- TFPM 2016
- BHC N/A
- Country
- TFPM Canada
- BHC Canada
- Employees
- TFPM N/A
- BHC N/A
- Industry
- TFPM Precious Metals
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- TFPM Industrials
- BHC Health Care
- Exchange
- TFPM Nasdaq
- BHC Nasdaq
- Market Cap
- TFPM 3.3B
- BHC 3.0B
- IPO Year
- TFPM N/A
- BHC N/A
- Fundamental
- Price
- TFPM $16.75
- BHC $8.18
- Analyst Decision
- TFPM Strong Buy
- BHC Hold
- Analyst Count
- TFPM 4
- BHC 4
- Target Price
- TFPM $20.50
- BHC $7.25
- AVG Volume (30 Days)
- TFPM 464.2K
- BHC 2.0M
- Earning Date
- TFPM 01-01-0001
- BHC 10-30-2024
- Dividend Yield
- TFPM 1.33%
- BHC N/A
- EPS Growth
- TFPM N/A
- BHC N/A
- EPS
- TFPM N/A
- BHC N/A
- Revenue
- TFPM $246,517,000.00
- BHC $9,474,000,000.00
- Revenue This Year
- TFPM $31.38
- BHC $9.59
- Revenue Next Year
- TFPM $12.69
- BHC $3.53
- P/E Ratio
- TFPM N/A
- BHC N/A
- Revenue Growth
- TFPM 25.66
- BHC 10.91
- 52 Week Low
- TFPM $11.75
- BHC $3.96
- 52 Week High
- TFPM $18.88
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- TFPM 48.96
- BHC 41.53
- Support Level
- TFPM $16.26
- BHC $8.15
- Resistance Level
- TFPM $16.68
- BHC $8.36
- Average True Range (ATR)
- TFPM 0.50
- BHC 0.28
- MACD
- TFPM -0.05
- BHC -0.17
- Stochastic Oscillator
- TFPM 46.34
- BHC 4.02
About TFPM Triple Flag Precious Metals Corp.
Triple Flag Precious Metals Corp is a precious-metals-focused streaming and royalty company. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Honduras, Mexico, Mongolia, Peru, South Africa, and the United States.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.